Literature DB >> 10985982

Diagnostic and treatment concerns in familial Mediterranean fever.

A Livneh1, P Langevitz.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal, recessively inherited disease, affecting people of Jewish, Arabic, Turkish and Armenian ancestry. The disease is the prototype of the periodic febrile syndromes. Its hallmark is short attacks of fever and painful manifestations in the abdomen, joints, chest, scrotum and skin. Chronic and protracted manifestations, particularly nephropathic amyloidosis, chronic arthritis, and protracted myalgia, may also occur in the disease. The diagnosis of FMF should be considered in individuals of an appropriate ethnic background who present with febrile disease of episodic nature. The differential diagnosis in this case is broad and includes a large number of infectious, inflammatory and genetic diseases. However, in most cases, the very specific general and site-restricted features of the FMF attacks on the one hand, and the absence of manifestations typical of other conditions on the other hand, determine the diagnosis of FMF. This chapter presents clues and tips that help in the diagnosis and treatment of FMF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985982     DOI: 10.1053/berh.2000.0089

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  50 in total

1.  Intrauterine device may trigger typical attacks of familial Mediterranean fever: a case report.

Authors:  Ilhan Kurultak; Can Kinalp; Mevlut Ceri; Tevfik Rıfkı Evrenkaya
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 2.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

3.  Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease.

Authors:  Ismail Simsek; Cem Koz; Nurcan Basar; Ismail Sari; Hakan Erdem; Salih Pay; Bunyamin Kisacik; Muhterem Bahce; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

4.  Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better?

Authors:  Victoria Akse-Onal; Erdal Sağ; Seza Ozen; Aysin Bakkaloglu; Nilgun Cakar; Nesrin Besbas; Safak Gucer
Journal:  Eur J Pediatr       Date:  2010-02-24       Impact factor: 3.183

5.  Familial Mediterranean fever protracted febrile myalgia in children: report of two cases.

Authors:  Vildan Ertekin; Mukadder Ayşe Selimoğlu; Handan Alp; Nebahat Yilmaz
Journal:  Rheumatol Int       Date:  2004-12-10       Impact factor: 2.631

6.  Sustained, progressive, nonresolving abdominal pain: a previously undescribed clinical presentation of familial Mediterranean fever.

Authors:  Marcelo Radisic; Joaquin Santamarina; Roberto Froment
Journal:  Clin Rheumatol       Date:  2005-12-03       Impact factor: 2.980

7.  Can we use faecal calprotectin to distinguish abdominal pain of familial Mediterranean fever (FMF) from acute appendicitis?

Authors:  Balahan Makay; Ozer Makay; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

8.  Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.

Authors:  Birol Balaban; Evren Yasar; Ahmet Ozgul; Kemal Dincer; Tunc Alp Kalyon
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

9.  The factors considered as trigger for the attacks in patients with familial Mediterranean fever.

Authors:  Omer Karadag; Abdurrahman Tufan; Veli Yazisiz; Kemal Ureten; Sedat Yilmaz; Muhammet Cinar; Ali Akdogan; Hakan Erdem; Mehmet Akif Ozturk; Salih Pay; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 2.631

10.  [Recurrent bouts of fever accompanied by abdominal pain and emesis].

Authors:  K Blassneck; G Nusko; J Benninger; E G Hahn; I A Harsch
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.